Developmental Research Program
The Developmental Research Program in the University of Iowa/Mayo Clinic Lymphoma SPORE supports innovative and scientifically sound projects investigating any area related to translational lymphoma research.
Funding in the Developmental Research Program is provided for one or two years to support novel lymphoma research projects. The long-term goal is translating the findings generated by developmental projects into a reduction in the incidence and mortality rates of lymphoma.
The Developmental Research Program:
- Encourages innovative laboratory and translationally relevant clinical studies
- Fosters extensive collaboration between basic science and clinical disciplines in translational research in lymphoma
- Encourages investigators to evaluate the potential of applying their research findings to translational research in lymphoma
- Generates new hypotheses to be tested in large-scale research projects or clinical trials that may lead to significant reduction of lymphoma incidence and mortality rates
With funds from the Lymphoma SPORE and from Mayo Clinic and University of Iowa institutional resources, the Developmental Research Program provides up to $50,000 for one or more projects each year.
The Lymphoma SPORE calls for applications annually. The SPORE's Developmental Research Committee formally reviews submissions.
Developmental Research Program funds are awarded based on scientific merit, originality and relevance to the objectives of the Lymphoma SPORE.
The director of the Developmental Research Program is:
- Steven R. Lentz, M.D., Ph.D., of the University of Iowa
The co-director is: